Asian pharma stocks extend declines after Trump slaps 100% levies on branded drugs
Investment
CNBC

Asian pharma stocks extend declines after Trump slaps 100% levies on branded drugs

Why This Matters

The 100% duties apply to "any branded or patented Pharmaceutical Product" except for companies that build manufacturing plants in the U.S., Trump said Friday.

September 26, 2025
04:39 AM
3 min read
AI Enhanced

Cityscape and Tokyo Tower at sunset, Tokyo, Japan.© Marco Bottigelli | Moment | Getty Imagess of Asian pharmaceutical companies fell Friday after U.S.

President Donald Trump announced fresh tariffs on furniture, heavy trucks and pharmaceutical ducts.Starting from Oct.

1, "any branded or patented Pharmaceutical duct" faces 100% duties, except for companies that build drug manufacturing plants in the U.S., Trump said in a Truth Social post early Friday.The Topix Pharma Index fell 1.47% ing the announcement.

Daiichi Sankyo and Chugai Pharmaceutical were among the companies that led losses, declining 2.11% and 3.64%, respectively.

Sumitomo Pharma ext losses, tumbling 5.33%.Heavyweight South Korean pharma stocks Samsung Biologics and SK Bio Pharmaceuticals were down 1.71% and 3.71%, respectively.Hong Kong-listed pharma companies also fell.

Alibaba Health Information nology and JD Health were also among the top losers list, falling 2.92% and 2.23%, respectively.In a separate Truth Social post, Trump said that imports of heavy trucks will be imposed a 25% levy.

Meanwhile, kitchen cabinets, bathroom vanities and "associated ducts" will face a 50% tariff, while a 30% tariff will be charged for upholstered furniture.Overnight in the U.S., Trump also signed an executive order apving a posal that would keep TikTok a in the U.S.

The transaction values the at $14 billion, according to Vice President JD Vance.Under the terms, which China must apve, a new joint-venture company will oversee TikTok's U.S.

, with ByteDance retaining less than a 20% stake.Japan's Nikkei 225 was flat, while the Topix rose 0.59% to reach a fresh record high.

Investors also assessed September inflation data from Japan's capital city of Tokyo.Core inflation in the city came in softer than expected at 2.5%, compared to expectations of 2.8% from economists polled by Reuters.

Headline inflation held steady at 2.5%.

Tokyo's inflation figures are widely considered to be a leading indicator of nationwide trends.South Korea's Kospi declined 2.02%, leading losses in Asia, while the small-cap Kosdaq retreated 1.57%.Australia's S&P/ASX 200 was marginally below the flatline.Hong Kong's Hang Seng index fell 0.86%, while the mainland Chinese CSI 300 index was flat.Overnight in the U.S., the pullback in on Wall Street continued for a third straight day, partly due to rising yields.The 10-year Treasury yield touched 4.2% after data on initial claims for unemployment insurance came in lower than expected.

Artificial intelligence play Oracle slid 5%, while Tesla was also among the day's laggards, falling 4%.The S&P 500 closed down 0.50% at 6,604.72, as did the Nasdaq Composite, which settled at 22,384.70.

The Dow Jones Industrial Average shed 0.38%, to finish at 45,947.32.—CNBC's Jonathan Varnian, Pia Singh and Sean Conlon contributed to this report.

FinancialBooklet Analysis

AI-powered insights based on this specific article

Key Insights

  • Inflation data often serves as a leading indicator for consumer spending and corporate pricing power

Questions to Consider

  • What does this inflation data suggest about consumer purchasing power and corporate margins?

Stay Ahead of the Market

Get weekly insights into market shifts, investment opportunities, and financial analysis delivered to your inbox.

No spam, unsubscribe anytime